Added to YB: 2025-07-09
Pitch date: 2025-07-07
NXS.AX [neutral]
Next Science Limited
+3.7%
current return
Author Info
Liquidation stocks is focused on liquidation and wind downs of listed stocks. I cover USA, Canada, UK, Europe, Australia, NZL, Japan, Hong Kong and other countries. Sign up for the newsletter.
Company Info
Next Science Limited engages in the research, development, and commercialization of technologies that resolve the issues in human health caused by biofilms, incumbent bacteria, fungus, viruses, and infections in North America, Australia, and New Zealand.
Market Cap
AUD 25.8M
Pitch Price
AUD 0.14
Price Target
0.15 (+13%)
Dividend
N/A
EV/EBITDA
-2.81
P/E
-2.44
EV/Sales
1.17
Sector
Health Care Equipment and Supplies
Category
special_situation
Liquidations Watchlist - Next Science Limited
NXS.AX (liquidation overview): Medical company selling biofilm infection products announces asset sale with est. USD$30M (AUD$0.155/share) distribution to shareholders. Stub will retain DME business assets (US distribution setup) with options being assessed. Key drivers: high probability of closing and stub value. NAV est. $0.155.
Read full article (1 min)